MedPath

A clinical study to assess the safety and efficacy of capsifen in a weight management study

Not Applicable
Registration Number
CTRI/2018/04/013157
Lead Sponsor
Akay Flavours and Aromatics Private Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Male or female healthy volunteers who have been practicing exercise or training

sessions for a minimum period of last 1 month to manage the obesity

2)Age 21-40 Years ( Both Inclusive)

3)Subjects with Body Mass Index (BMI) between 27Kg/m to 40 Kg/m

4)Shall agree to sign an Informed Consent Document

Exclusion Criteria

1)Subject with history of cardiovascular, Type 2 Diabetes mellitus, pulmonary, hepatic, gastrointestinal problems, and renal problems

2)Subjects with a history of anorexia nevosa or other eating disorders

3)Subjects with known history of gastrointestinal irregularities

4)Prior use of anti obesity agents

5)History of surgical therapy for obesity

6)Subjects with known genetical syndromes which cause obesity

7)Subjects who are currently under any kind of long term medication

8)Subjects with a known allergy to herbal products

9)Subjects with abnormal biochemical or haematological values

10)Pregnant or Lactating Women

11)Any condition that in Opinion of the Investigator, does not justify the Subjectsâ?? participation in the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in Energy Expenditure in comparison with baseline valuesTimepoint: Day 0, Day 56
Secondary Outcome Measures
NameTimeMethod
Change in Biochemical Markers in comparison with basline valuesTimepoint: Day 0, Day 56;Tolerabily, safety and adverse event assessmentTimepoint: Day 0, Day 28, Day 56
© Copyright 2025. All Rights Reserved by MedPath